Literature DB >> 11994501

Oxidant-mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease.

Mark B Hampton1, Margret C M Vissers, Jacqueline I Keenan, Christine C Winterbourn.   

Abstract

The removal of neutrophils from inflammatory sites is essential for the resolution of inflammation. Surface changes, including phosphatidylserine exposure, label neutrophils for phagocytosis by macrophages. Here, we demonstrate that externalization of phosphatidylserine and uptake by monocyte-derived macrophages occurred in human neutrophils ingesting Staphylococcus aureus. Both processes were dependent on oxidant production from the neutrophil NADPH oxidase. There was no requirement for myeloperoxidase, and H(2)O(2) was identified as the most likely trigger for PS exposure. We hypothesize that clearance of stimulated neutrophils would be delayed in chronic granulomatous disease (CGD) neutrophils, which lack a functional NADPH oxidase. To explore this possibility, heat-killed S. aureus were injected into the peritoneum of CGD and normal mice. Elevated neutrophil numbers were observed in the inflammatory exudate of the CGD animals, consistent with impaired recognition and clearance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994501

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  28 in total

1.  Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production.

Authors:  Colleen J Lewis; Brian A Cobb
Journal:  Eur J Immunol       Date:  2011-08-04       Impact factor: 5.532

Review 2.  Role of Nox2 in elimination of microorganisms.

Authors:  Balázs Rada; Csilla Hably; András Meczner; Csaba Timár; Gergely Lakatos; Péter Enyedi; Erzsébet Ligeti
Journal:  Semin Immunopathol       Date:  2008-06-24       Impact factor: 9.623

Review 3.  The roles of NADPH oxidase in modulating neutrophil effector responses.

Authors:  Melody Y Zeng; Irina Miralda; Cortney L Armstrong; Silvia M Uriarte; Juhi Bagaitkar
Journal:  Mol Oral Microbiol       Date:  2019-02-07       Impact factor: 3.563

4.  A functional NADPH oxidase prevents caspase involvement in the clearance of phagocytic neutrophils.

Authors:  Rachel P Wilkie; Margret C M Vissers; Mike Dragunow; Mark B Hampton
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

5.  Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-γ in a nitric oxide-dependent manner.

Authors:  Ruby Fernandez-Boyanapalli; Kathleen A McPhillips; S Courtney Frasch; William J Janssen; Mary C Dinauer; David W H Riches; Peter M Henson; Aideen Byrne; Donna L Bratton
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

6.  Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Kathleen McPhillips; R William Vandivier; Brian L Harry; David W H Riches; Peter M Henson; Donna L Bratton
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

7.  Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism.

Authors:  Pei Wang; Yunfei Wu; Xiaoming Li; Xiaofeng Ma; Liangwei Zhong
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

8.  Neutrophils are resistant to Yersinia YopJ/P-induced apoptosis and are protected from ROS-mediated cell death by the type III secretion system.

Authors:  Justin L Spinner; Keun Seok Seo; Jason L O'Loughlin; Jennifer A Cundiff; Scott A Minnich; Gregory A Bohach; Scott D Kobayashi
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

9.  Impaired macrophage function following bacterial stimulation in chronic granulomatous disease.

Authors:  Farooq Z Rahman; Bu'Hussain Hayee; Ronnie Chee; Anthony W Segal; Andrew M Smith
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

Review 10.  Death begets a new beginning.

Authors:  Lidia Bosurgi; Lindsey D Hughes; Carla V Rothlin; Sourav Ghosh
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.